This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the efficacy and safety of ACT regimens for treating uncomplicated P. falciparum malaria in the context of HIV co-infected or exposed children. Other objectives are to assess whether drug-related adverse events are more common in HIV-positive compared to HIV-negative children and whether antimalarials are less effective in HIV-positive compared to HIV-negative children.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.